Corporate Compliance

FDA issues updates, makes no mention of reauthorization

Mammography Regulation and Reimbursement Report, July 1, 2008

This is an excerpt from a member only article. To read the article in its entirety, please login.

If you’re wondering when MQSA will be reauthorized, you’re not alone. Authorization from the FDA had been set to occur in fall 2007, but Dan Oakey, Florida MQSA inspector, says the absence of information from the FDA on the subject is an indication that the process will not likely move forward anytime soon.

However, the FDA Mammography Advisory Committee voted in November 2007 to recommend that MQSA reauthorization include accreditation for stereotactic breast biopsy. It was a main focus at the National Mammography Quality Assurance Advisory Committee meeting, too.

 

This is an excerpt from a member only article. To read the article in its entirety, please login.

Comments

0 comments on “FDA issues updates, makes no mention of reauthorization

 

    Strategies for Health Care Compliance
  • Strategies for Health Care Compliance

    News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...

  • Compliance Monitor

    This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...

  • Medicare Weekly Update

    Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...

  • Medicare Update for Physician Services

    Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...

Most Popular

Related Articles